ArticleCancer science2026

FOLFIRINOX vs. Gemcitabine/Nab-Paclitaxel for Pancreatic Cancer by BRCA2 and TMB Status: A Japanese C-CAT Database Study.

Kazuyuki Mizuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.